Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00ABE
|
|||
| Former ID |
DNCL001820
|
|||
| Drug Name |
ALD-301
|
|||
| Indication | Ischemia [ICD-11: 8B10-8B11; ICD-9: 459.89] | Phase 2 | [1] | |
| Peripheral arterial disease [ICD-11: BD4Z; ICD-10: I73, I73.9] | Phase 2 | [2] | ||
| Company |
Aldagen Durham, NC
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029583) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.